CANTATORE, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 16.652
EU - Europa 11.193
AS - Asia 8.199
SA - Sud America 1.387
Continente sconosciuto - Info sul continente non disponibili 1.148
AF - Africa 145
OC - Oceania 23
Totale 38.747
Nazione #
US - Stati Uniti d'America 16.423
CN - Cina 3.129
IE - Irlanda 3.085
SG - Singapore 2.637
UA - Ucraina 2.120
RU - Federazione Russa 1.790
SE - Svezia 1.376
BR - Brasile 1.138
HK - Hong Kong 854
FR - Francia 669
DE - Germania 546
IT - Italia 506
VN - Vietnam 472
FI - Finlandia 410
IN - India 304
TR - Turchia 295
GB - Regno Unito 283
BD - Bangladesh 155
CZ - Repubblica Ceca 118
CA - Canada 112
AR - Argentina 99
MX - Messico 64
IQ - Iraq 63
PL - Polonia 52
EC - Ecuador 47
NL - Olanda 45
AT - Austria 41
JP - Giappone 37
ZA - Sudafrica 37
ID - Indonesia 36
BE - Belgio 33
ES - Italia 26
UZ - Uzbekistan 25
PK - Pakistan 23
CO - Colombia 21
EG - Egitto 20
EU - Europa 19
VE - Venezuela 19
MA - Marocco 18
PH - Filippine 18
CL - Cile 17
JO - Giordania 16
PY - Paraguay 16
SA - Arabia Saudita 16
AZ - Azerbaigian 14
PE - Perù 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
KE - Kenya 13
LT - Lituania 13
JM - Giamaica 11
RO - Romania 10
CR - Costa Rica 9
DZ - Algeria 9
NP - Nepal 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
UY - Uruguay 9
DK - Danimarca 8
CH - Svizzera 7
IL - Israele 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
AL - Albania 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
MY - Malesia 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
GT - Guatemala 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
MN - Mongolia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
GA - Gabon 2
Totale 37.587
Città #
Dublin 3.081
San Jose 2.437
Dallas 1.815
Jacksonville 1.424
Chandler 1.330
Singapore 1.229
Dearborn 985
Ashburn 892
Nyköping 880
Hong Kong 845
Nanjing 650
Beijing 638
Santa Clara 442
Council Bluffs 388
Lauterbourg 344
Wilmington 340
Princeton 326
Columbus 321
Munich 278
San Mateo 224
Nanchang 210
Moscow 207
New York 193
The Dalles 186
Helsinki 175
Los Angeles 175
Ho Chi Minh City 165
Shenyang 148
Boardman 141
Ann Arbor 121
Hebei 113
Des Moines 107
Jiaxing 102
Brno 97
São Paulo 97
Tianjin 96
Kunming 91
Woodbridge 91
Hanoi 83
Changsha 75
Shanghai 73
Foggia 70
Atlanta 53
Guangzhou 53
Hangzhou 48
London 46
Zhengzhou 46
Chicago 45
Frankfurt am Main 44
Orem 44
Jinan 42
Nuremberg 41
Milan 39
San Francisco 36
Brooklyn 35
Phoenix 35
Dong Ket 34
Hilden 32
Ningbo 29
Baghdad 28
Norwalk 28
Tokyo 28
Warsaw 28
Brussels 27
Hillsboro 27
Rio de Janeiro 27
Seattle 27
Taizhou 27
Washington 26
Lanzhou 25
Montreal 25
Toronto 25
Chennai 24
Curitiba 24
Stevenage 24
Guayaquil 23
Turku 23
Pune 22
Rome 22
Tashkent 21
Amsterdam 20
Assago 20
Auburn Hills 20
Changchun 20
Da Nang 20
Falkenstein 20
Haiphong 20
Hanover 20
Manchester 20
Boston 19
Hefei 19
Belo Horizonte 18
Philadelphia 18
Stockholm 18
Xi'an 18
Bari 17
Brasília 17
Naples 17
Orange 17
Salvador 17
Totale 23.293
Nome #
Serious spondylodiscitis, septic sacroiliitis and multiple abscesses after ozone therapy for low back pain: A case report on good response to combined treatment with empiric antibiotic and neridronate 1.087
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 556
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 486
Visceral fat dysfunctions in the rat social isolation model of psychosis 264
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 219
A case of rhupus treated with filgotinib: A promising therapeutic perspective 201
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 196
25-Hydroxycholecalciferol in experimental osteoporosis 175
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 161
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 160
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 158
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 156
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 156
Extra-skeletal effects of bisphosphonates. 155
Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells 154
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 151
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort 149
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 148
Adult Scheuermann's disease as cause of mechanic dorsalgia 147
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 147
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 143
A case of chondrodysplasia.Dolichomelic spondylo-epiphyseal chondrodysplasia 143
Normal serum concentrations of 1,25 dihydroxyvitamin D in osteoporosis 143
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 142
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 142
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 140
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 139
SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN ITALIAN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM MULTICENTER GIRRCS (GRUPPO ITALIANO DI RICERCA IN REUMATOLOGIA CLINICA E SPERIMENTALE) STUDY 136
Ulcerative colitis and systemic lupus erythematosus. Minerva Med 135
Clodronate inhibits angiogenesis in vitro and in vivo 134
Effects of anabolic steroids, salmon calcitonin and 25OH-D3 on rat bones 134
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 132
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 132
Corticosteroids, a review. 131
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 131
Anti-TNF-α and risk of infections: the experience in one center. 131
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 131
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 130
Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts 129
Linear bone densitometry by monochromatic photon absorptiometry. A study of a normal population in Apulia 129
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 128
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 128
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause 127
Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3 127
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 127
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 127
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 126
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 126
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 126
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated withphosphorus and salmon calcitonin 125
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 125
Beta-2 microglobulin in osteoarthrosis 125
Bisphosphonates: effects on osteoblast. 124
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 124
Post biliopancreatic by-pass arthritis dermatitis syndrome 123
Bone effects of biologic drugs in rheumatoid arthritis. 123
A sequential treatment of osteoporosis with anabolic steroids and salmon calcitonin 122
Serum 25(OH)D3 in theApulian population (Southern Italy). Epidemiologic study 122
Echographic study of Tietze's syndrome. 121
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 121
Mitochondrial disease mimicking polymyositis: a case report 119
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. 119
La coxalgia 119
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 119
BIOLOGIC THERAPIES AND INFECTIONS IN THE DAILY PRACTICE: A STUDY ON HISTORICAL COHORT FROM 3 ITALIAN RHEUMATOLOGIC UNITS 119
Monitoring biological action of rapamycin in renal transplantation. 118
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 118
Vitamin D and the immune system 117
IgA nephropathy in systemic lupus erythematosus. 117
Fascite eosinofila: entità clinica a se stante o variante clinica della sclerosi sistemica? 117
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 117
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 117
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 117
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 116
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 116
Serum osteocalcin levels in normal humans of different sex and age. An epidemiological study. 116
Effects of nandrolonedecanoate on plasma calcitonin, parathormone and vitamin D, in elderly women 116
Systemic effects of Wnt signaling 116
Bisphosphonates and osteoarthritis 116
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. 115
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 115
Two-Years Survival of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis and Predictors Thereof in Real-Life Settings 115
AB0253 BIOMARKERS OF CLINICAL RESPONSE TO IL6-R BLOCKADE IN DMARDS INCOMPLETE RESPONDERS (AR-BIOM TRIAL): IL23 AND BAFF AS BIOLOGICAL TARGETS, AND ALBUMIN AS BIOLOGICAL PREDICTOR 115
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 115
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 115
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 115
Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 114
Osteocytes: central conductors of bone biology in normal and pathological conditions 114
Effects of anabolic steroids, 1.25(OH)D3 and calcitonin on osteocalcin and calciotropic hormones 114
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 114
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 114
AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea 114
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 114
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial 113
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 113
Osteocalcin: Skeletal and extra-skeletal effects 113
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 113
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 113
Effect of calcitonin or the anabolic steroid decadurabolin on serum B2 microglobulin in osteoporotic post menopausal women 112
Integrine expression on human osteoblasts in osteoarthritis 112
Totale 14.851
Categoria #
all - tutte 208.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.388 0 23 14 10 123 35 45 141 250 222 93 432
2022/20236.944 630 249 282 364 352 632 34 506 3.515 68 150 162
2023/20241.175 179 60 66 51 79 278 23 50 15 47 27 300
2024/20255.508 305 51 118 188 184 824 611 401 1.458 371 482 515
2025/202611.449 578 997 2.285 1.329 463 492 2.195 1.041 816 673 287 293
2026/20272.018 1.189 829 0 0 0 0 0 0 0 0 0 0
Totale 38.747